Back to search
Rejection of Kidney Allograft
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Rejection of Kidney Allograft trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Rejection of Kidney Allograft trials you may qualify forChronic Allograft Nephropathy (CAN)/Interstitial fibrosis and Tubular Atrophy (IFTA) is responsible for most kidney transplant failures. CAN/IFTA on a 3 month k…
The purpose of this study is to evaluate the benefits and risks of conversion of existing adolescent kidney allograft recipients aged 12 to less than 18 years o…
The goal of the Australian Genomics of Chronic Allograft Dysfunction (AUSCAD) study is a single centre (Westmead Hospital), prospective, observational study, wh…
This clinical trial investigates the transplantation of donor kidneys that have been genetically modified ex vivo using CRISPR-Cas9 genome editing to reduce imm…
This study will evaluate the safety, PK, and efficacy of AT 1501 in patients undergoing kidney transplantation.
Microvascular inflammation in kidney allografts has been widely reappraised in the recent update of Banff classification. There is a critical need to better und…
This study was to compare CFZ533 to tacrolimus (TAC) in prevention of organ rejection in kidney transplant.
With this project, the research team aims to identify the molecular pathways associated with the response to extracorporeal photonchemioapheresis (ECP) in kidne…
The goal of this observational study is to determine phenotypic, transcriptional, and epigenetic underpinnings of renal allograft rejection in renal transplant…